iProXProteomicsWei LongMus Musculushttp://www.iprox.org/page/project.html?id=IPX00181530003028463099@qq.comKunming Medical UniversityiProXfalseAnlotinib Treatment of Papillary Thyroid Carcinoma via Inhibition of EGFRThis study explored the therapeutic effect and molecular mechanisms of anlotinib in a model of papillary thyroid carcinoma (PTC) with BRAFV600E and TERT promoter cooccurring mutations, providing a theoretical basis for identifying biomarkers for predicting the effectiveness of anlotinib treatment in radioactive iodine refractory (RAIR)-PTC.Mon Jul 13 00:00:00 BST 2026PXD08101810090